Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer
Volume: 39, Issue: 11, Pages: 787.e17 - 787.e21
Published: Nov 1, 2021
Abstract
Metastatic bladder cancer is an aggressive disease that can often be difficult to diagnose and stage with conventional cross-sectional imaging. The primary objective of this study was to determine the clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose (18F-FDG) PET/MRI for surveillance and restaging of patients with muscle-invasive, locally advanced, and metastatic bladder cancer compared to conventional imaging methods.This retrospective...
Paper Details
Title
Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer
Published Date
Nov 1, 2021
Volume
39
Issue
11
Pages
787.e17 - 787.e21
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History